Answers are grounded in this paper and cite their sources.
Baseline maximum standardised uptake value does not predict survival in high-tumour-burden follicular lymphoma treated with first-line immunochemotherapy, but identifies patients at risk of histological transformation: no transformation occurred below the cohort median. Its role is to guide biopsy and surveillance rather than therapeutic stratification.
No takes yet. Share an insight, caveat, or question.
Bouguern et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: